353 related articles for article (PubMed ID: 29429758)
1. The immunobiology of mucosal-associated invariant T cell (MAIT) function in primary biliary cholangitis: Regulation by cholic acid-induced Interleukin-7.
Jiang X; Lian M; Li Y; Zhang W; Wang Q; Wei Y; Zhang J; Chen W; Xiao X; Miao Q; Bian Z; Qiu D; Fang J; Ansari AA; Leung PSC; Coppel RL; Tang R; Gershwin ME; Ma X
J Autoimmun; 2018 Jun; 90():64-75. PubMed ID: 29429758
[TBL] [Abstract][Full Text] [Related]
2. Persistent reduction of mucosal-associated invariant T cells in primary biliary cholangitis.
Setsu T; Yamagiwa S; Tominaga K; Kimura N; Honda H; Kamimura H; Tsuchiya A; Takamura M; Terai S
J Gastroenterol Hepatol; 2018 Jun; 33(6):1286-1294. PubMed ID: 29266628
[TBL] [Abstract][Full Text] [Related]
3. CXCL12-CXCR4-Mediated Chemotaxis Supports Accumulation of Mucosal-Associated Invariant T Cells Into the Liver of Patients With PBC.
Chen Z; Liu S; He C; Sun J; Wang L; Chen H; Zhang F
Front Immunol; 2021; 12():578548. PubMed ID: 33815355
[No Abstract] [Full Text] [Related]
4. Decreased infiltration of CD4
Yu K; Li P; Xu T; Xu J; Wang K; Chai J; Zhao D; Liu Y; Wang Y; Ma J; Fan L; Guo S; Li Z; Li M; Wang Z
Pathol Res Pract; 2021 Jan; 217():153291. PubMed ID: 33249399
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid impairs liver-infiltrating T-cell chemotaxis through IFN-γ and CX3CL1 production in primary biliary cholangitis.
Shimoyama S; Kawata K; Ohta K; Chida T; Suzuki T; Tsuneyama K; Shimoda S; Kurono N; Leung PSC; Gershwin ME; Suda T; Kobayashi Y
Eur J Immunol; 2021 Jun; 51(6):1519-1530. PubMed ID: 33710617
[TBL] [Abstract][Full Text] [Related]
6. Obeticholic acid for the treatment of primary biliary cholangitis.
Ali AH; Lindor KD
Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
[TBL] [Abstract][Full Text] [Related]
7. RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis.
Hao YL; Bian ZL; Ju LL; Liu Y; Qin G
Dig Dis Sci; 2020 Feb; 65(2):470-479. PubMed ID: 31377883
[TBL] [Abstract][Full Text] [Related]
8. Primary sclerosing cholangitis leads to dysfunction and loss of MAIT cells.
von Seth E; Zimmer CL; Reuterwall-Hansson M; Barakat A; Arnelo U; Bergquist A; Ivarsson MA; Björkström NK
Eur J Immunol; 2018 Dec; 48(12):1997-2004. PubMed ID: 30252934
[TBL] [Abstract][Full Text] [Related]
9. Mucosal-Associated Invariant T Cells Improve Nonalcoholic Fatty Liver Disease Through Regulating Macrophage Polarization.
Li Y; Huang B; Jiang X; Chen W; Zhang J; Wei Y; Chen Y; Lian M; Bian Z; Miao Q; Peng Y; Fang J; Wang Q; Tang R; Gershwin ME; Ma X
Front Immunol; 2018; 9():1994. PubMed ID: 30233587
[TBL] [Abstract][Full Text] [Related]
10. Human liver CD8
Rha MS; Han JW; Kim JH; Koh JY; Park HJ; Kim SI; Kim MS; Lee JG; Lee HW; Lee DH; Kim W; Park JY; Joo DJ; Park SH; Shin EC
J Hepatol; 2020 Sep; 73(3):640-650. PubMed ID: 32247824
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action.
Poupon R
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S3-12. PubMed ID: 23141891
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of TIPE2 contributes to the hyperreactivity of monocyte to Toll-like receptor ligands in primary biliary cirrhosis.
Qin B; Wei T; Wang L; Ma N; Tang Q; Liang Y; Yang Z; Zhou L; Zhong R
J Gastroenterol Hepatol; 2016 Jun; 31(6):1177-83. PubMed ID: 26644386
[TBL] [Abstract][Full Text] [Related]
13. Primary biliary cirrhosis and bile acids.
Corpechot C
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S13-20. PubMed ID: 23141888
[TBL] [Abstract][Full Text] [Related]
14. Alcohol Abstinence Does Not Fully Reverse Abnormalities of Mucosal-Associated Invariant T Cells in the Blood of Patients With Alcoholic Hepatitis.
Li W; Lin EL; Liangpunsakul S; Lan J; Chalasani S; Rane S; Puri P; Kamath PS; Sanyal AJ; Shah VH; Radaeva S; Crabb DW; Chalasani N; Yu Q
Clin Transl Gastroenterol; 2019 Jun; 10(6):e00052. PubMed ID: 31211759
[TBL] [Abstract][Full Text] [Related]
15. Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells.
Arenas F; Hervias I; Uriz M; Joplin R; Prieto J; Medina JF
J Clin Invest; 2008 Feb; 118(2):695-709. PubMed ID: 18188457
[TBL] [Abstract][Full Text] [Related]
16. CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis.
Wang L; Sun Y; Zhang Z; Jia Y; Zou Z; Ding J; Li Y; Xu X; Jin L; Yang T; Li Z; Sun Y; Zhang JY; Lv S; Chen L; Li B; Gershwin ME; Wang FS
Hepatology; 2015 Feb; 61(2):627-38. PubMed ID: 25042122
[TBL] [Abstract][Full Text] [Related]
17. The challenges of primary biliary cholangitis: What is new and what needs to be done.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D; Vierling JM; Adams D; Alpini G; Banales JM; Beuers U; Björnsson E; Bowlus C; Carbone M; Chazouillères O; Dalekos G; De Gottardi A; Harada K; Hirschfield G; Invernizzi P; Jones D; Krawitt E; Lanzavecchia A; Lian ZX; Ma X; Manns M; Mavilio D; Quigley EM; Sallusto F; Shimoda S; Strazzabosco M; Swain M; Tanaka A; Trauner M; Tsuneyama K; Zigmond E; Gershwin ME
J Autoimmun; 2019 Dec; 105():102328. PubMed ID: 31548157
[TBL] [Abstract][Full Text] [Related]
18. IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis.
Gracey E; Qaiyum Z; Almaghlouth I; Lawson D; Karki S; Avvaru N; Zhang Z; Yao Y; Ranganathan V; Baglaenko Y; Inman RD
Ann Rheum Dis; 2016 Dec; 75(12):2124-2132. PubMed ID: 27165176
[TBL] [Abstract][Full Text] [Related]
19. Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot study.
Yang H; Yang H; Wang L; Shi H; Liu B; Lin X; Chang Q; Chen JDZ; Duan Z
BMC Complement Med Ther; 2020 Aug; 20(1):242. PubMed ID: 32738911
[TBL] [Abstract][Full Text] [Related]
20. [Research progress on risk factors for poor response of ursodeoxycholic acid in primary biliary cholangitis].
Yuan Z; Jia G; Han Y
Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):73-76. PubMed ID: 30685931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
